Algert Global LLC Zymeworks Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.82 - $7.7 $399,168 - $637,675
-82,815 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.0 - $16.98 $367,590 - $1.04 Million
61,265 Added 284.29%
82,815 $542,000
Q4 2021

Feb 14, 2022
BUY
$15.19 - $29.33 $142,026 - $274,235
9,350 Added 76.64%
21,550 $353,000
Q3 2021

Nov 15, 2021
BUY
$27.35 - $37.28 $333,670 - $454,816
12,200 New
12,200 $354,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $850M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email